Search

Your search keyword '"Juffermans, Nicole P"' showing total 1,410 results
Start Over Author "Juffermans, Nicole P"
1,410 results on '"Juffermans, Nicole P"'

1. Environmental sustainability in intensive care: the path forward. An ESICM Green Paper

Author

De Waele, Jan J., Hunfeld, Nicole, Baid, Heather, Ferrer, Ricard, Iliopoulou, Katerina, Ioan, Ana-Maria, Leone, Marc, Ostermann, Marlies, Scaramuzzo, Gaetano, Theodorakopoulou, Maria, Touw, Hugo, Citerio, Giuseppe, Derde, Lennie P. G., Donadello, Katia, Juffermans, Nicole P., Galarza, Laura, Grasselli, Giacomo, Maggiore, Salvatore Maurizio, Martin-Loeches, Ignacio, Alexandre, Joel, Cecconi, Maurizio, and Azoulay, Elie

Published
2024
Full Text
View/download PDF

9. European Society of Intensive Care Medicine clinical practice guideline on fluid therapy in adult critically ill patients. Part 1: the choice of resuscitation fluids

Author

Arabi, Yaseen M., Belley-Cote, Emilie, Carsetti, Andrea, De Backer, Daniel, Donadello, Katia, Juffermans, Nicole P., Hammond, Naomi, Laake, Jon Henrik, Liu, Dawei, Maitland, Kathryn, Messina, Antonio, Møller, Morten Hylander, Poole, Daniele, Mac Sweeney, Rob, Vincent, Jean-Louis, Zampieri, Fernando G., and AlShamsi, Fayez

Published
2024
Full Text
View/download PDF

14. Ten tips on fever

Author

Leone, Marc, Juffermans, Nicole P., and Nielsen, Nathan D.

Subjects
Ketamine -- Dosage and administration, Critically ill -- Care and treatment, Physiology, Pathological -- Analysis, Health care industry
Abstract

Author(s): Marc Leone [sup.1] [sup.2] , Nicole P. Juffermans [sup.3] [sup.4] , Nathan D. Nielsen [sup.5] [sup.6] Author Affiliations: (1) grid.5399.6, 0000 0001 2176 4817, Department of anesthesiology and intensive [...]

Published
2023
Full Text
View/download PDF

15. ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies

Author

Grasselli, Giacomo, Calfee, Carolyn S., Camporota, Luigi, Poole, Daniele, Amato, Marcelo B. P., Antonelli, Massimo, Arabi, Yaseen M., Baroncelli, Francesca, Beitler, Jeremy R., Bellani, Giacomo, Bellingan, Geoff, Blackwood, Bronagh, Bos, Lieuwe D. J., Brochard, Laurent, Brodie, Daniel, Burns, Karen E. A., Combes, Alain, D’Arrigo, Sonia, De Backer, Daniel, Demoule, Alexandre, Einav, Sharon, Fan, Eddy, Ferguson, Niall D., Frat, Jean-Pierre, Gattinoni, Luciano, Guérin, Claude, Herridge, Margaret S., Hodgson, Carol, Hough, Catherine L., Jaber, Samir, Juffermans, Nicole P., Karagiannidis, Christian, Kesecioglu, Jozef, Kwizera, Arthur, Laffey, John G., Mancebo, Jordi, Matthay, Michael A., McAuley, Daniel F., Mercat, Alain, Meyer, Nuala J., Moss, Marc, Munshi, Laveena, Myatra, Sheila N., Ng Gong, Michelle, Papazian, Laurent, Patel, Bhakti K., Pellegrini, Mariangela, Perner, Anders, Pesenti, Antonio, Piquilloud, Lise, Qiu, Haibo, Ranieri, Marco V., Riviello, Elisabeth, Slutsky, Arthur S., Stapleton, Renee D., Summers, Charlotte, Thompson, Taylor B., Valente Barbas, Carmen S., Villar, Jesús, Ware, Lorraine B., Weiss, Björn, Zampieri, Fernando G., Azoulay, Elie, and Cecconi, Maurizio

Published
2023
Full Text
View/download PDF

20. Hemostasis

Author

Dujardin, Romein W. G., Kleinveld, Derek J. B., Juffermans, Nicole P., Cecconi, Maurizio, Series Editor, De Backer, Daniel, Series Editor, Molnar, Zsolt, editor, Ostermann, Marlies, editor, and Shankar-Hari, Manu, editor

Published
2023
Full Text
View/download PDF

23. Ventilation practices in burn patients—an international prospective observational cohort study

Author

Schultz, Marcus J, Horn, Janneke, Hollmann, Markus W, Preckel, Benedikt, Glas, Gerie J, Colpaert, Kirsten, Malbrain, Manu, Neto, Ary Serpa, Asehnoune, Karim, de Abreu, Marcello Gamma, Martin-Loeches, Ignacio, Pelosi, Paolo, Sjöberg, Folke, Binnekade, Jan M, Cleffken, Berry, Juffermans, Nicole P, Knape, Paul, Loef, Bert G, Mackie, David P, Enkhbaatar, Perenlei, Depetris, Nadia, Perner, Anders, Herrero, Eva, Cachafeiro, Lucia, Jeschke, Marc, Lipman, Jeffrey, Legrand, Matthieu, Horter, Johannes, Lavrentieva, Athina, Glas, Gerie, Kazemi, Alex, Guttormsen, Anne Berit, Huss, Frederik, Kol, Mark, Wong, Helen, Starr, Therese, De Crop, Luc, de Oliveira Filho, Wilson, Silva, João Manoel, Grion, Cintia MC, Jeschke, Marc G, Burnett, Marjorie, Mondrup, Frederik, Ravat, Francois, Fontaine, Mathieu, Asehoune, Karim, Le Floch, Renan, Jeanne, Mathieu, Bacus, Morgane, Chaussard, Maïté, Lehnhardt, Marcus, Mikhail, Bassem Daniel, Gille, Jochen, Sharkey, Aidan, Trommel, Nicole, Reidinga, Auke C, Vieleers, Nadine, Tilsley, Anna, Onarheim, Henning, Bouza, Maria Teresa, Agrifoglio, Alexander, Fredén, Filip, Palmieri, Tina, Painting, Lynda E, and investigators, LAMiNAR

Subjects
Paediatrics, Biomedical and Clinical Sciences, Physical Injury - Accidents and Adverse Effects, Clinical Research, Lung, Respiratory, Mechanical ventilation, Inhalation trauma, Lung-protective, Critical care, LAMiNAR investigators, Clinical sciences, Medical biotechnology, Biomedical engineering
Abstract

BackgroundIt is unknown whether lung-protective ventilation is applied in burn patients and whether they benefit from it. This study aimed to determine ventilation practices in burn intensive care units (ICUs) and investigate the association between lung-protective ventilation and the number of ventilator-free days and alive at day 28 (VFD-28).MethodsThis is an international prospective observational cohort study including adult burn patients requiring mechanical ventilation. Low tidal volume (V T) was defined as V T ≤ 8 mL/kg predicted body weight (PBW). Levels of positive end-expiratory pressure (PEEP) and maximum airway pressures were collected. The association between V T and VFD-28 was analyzed using a competing risk model. Ventilation settings were presented for all patients, focusing on the first day of ventilation. We also compared ventilation settings between patients with and without inhalation trauma.ResultsA total of 160 patients from 28 ICUs in 16 countries were included. Low V T was used in 74% of patients, median V T size was 7.3 [interquartile range (IQR) 6.2-8.3] mL/kg PBW and did not differ between patients with and without inhalation trauma (p = 0.58). Median VFD-28 was 17 (IQR 0-26), without a difference between ventilation with low or high V T (p = 0.98). All patients were ventilated with PEEP levels ≥5 cmH2O; 80% of patients had maximum airway pressures

Published
2021

24. Acute respiratory distress syndrome subphenotypes and therapy responsive traits among preclinical models: protocol for a systematic review and meta-analysis

Author

Carla, Adrien, Pereira, Bruno, Boukail, Hanifa, Audard, Jules, Pinol-Domenech, Nathalie, De Carvalho, Manuela, Blondonnet, Raiko, Zhai, Ruoyang, Morand, Dominique, Lambert, Céline, Sapin, Vincent, Ware, Lorraine B, Calfee, Carolyn S, Bastarache, Julie A, Laffey, John G, Juffermans, Nicole P, Bos, Lieuwe D, Artigas, Antonio, Rocco, Patricia RM, Matthay, Michael A, McAuley, Daniel F, Constantin, Jean-Michel, and Jabaudon, Matthieu

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Lung, Rare Diseases, Acute Respiratory Distress Syndrome, Respiratory, Adrenergic beta-Agonists, Animals, Disease Models, Animal, Humans, Phenotype, Positive-Pressure Respiration, Randomized Controlled Trials as Topic, Respiratory Distress Syndrome, Treatment Outcome, Systematic review protocol, Acute respiratory distress syndrome, Preclinical, Subphenotypes, ESICM Translational Biology Group of the Acute Respiratory Failure section, Cardiorespiratory Medicine and Haematology, Respiratory System, Cardiovascular medicine and haematology, Clinical sciences
Abstract

BackgroundSubphenotypes were recently reported within clinical acute respiratory distress syndrome (ARDS), with distinct outcomes and therapeutic responses. Experimental models have long been used to mimic features of ARDS pathophysiology, but the presence of distinct subphenotypes among preclinical ARDS remains unknown. This review will investigate whether: 1) subphenotypes can be identified among preclinical ARDS models; 2) such subphenotypes can identify some responsive traits.MethodsWe will include comparative preclinical (in vivo and ex vivo) ARDS studies published between 2009 and 2019 in which pre-specified therapies were assessed (interleukin (IL)-10, IL-2, stem cells, beta-agonists, corticosteroids, fibroblast growth factors, modulators of the receptor for advanced glycation end-products pathway, anticoagulants, and halogenated agents) and outcomes compared to a control condition. The primary outcome will be a composite of the four key features of preclinical ARDS as per the American Thoracic Society consensus conference (histologic evidence of lung injury, altered alveolar-capillary barrier, lung inflammatory response, and physiological dysfunction). Secondary outcomes will include the single components of the primary composite outcome, net alveolar fluid clearance, and death. MEDLINE, Embase, and Cochrane databases will be searched electronically and data from eligible studies will be extracted, pooled, and analyzed using random-effects models. Individual study reporting will be assessed according to the Animal Research: Reporting of In Vivo Experiments guidelines. Meta-regressions will be performed to identify subphenotypes prior to comparing outcomes across subphenotypes and treatment effects.DiscussionThis study will inform on the presence and underlying pathophysiological features of subphenotypes among preclinical models of ARDS and should help to determine whether sufficient evidence exists to perform preclinical trials of subphenotype-targeted therapies, prior to potential clinical translation.Systematic review registrationPROSPERO (ID: CRD42019157236).

Published
2020

25. Red‐blood‐cell manufacturing methods and storage solutions differentially induce pulmonary cell activation

Author

Wirtz, Mathijs R, Almizraq, Ruqayyah J, Weber, Nina C, Norris, Philip J, Pandey, Suchitra, Spinella, Philip C, Muszynski, Jennifer A, Acker, Jason P, and Juffermans, Nicole P

Subjects
Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Acute Respiratory Distress Syndrome, Lung, Rare Diseases, Hematology, 2.1 Biological and endogenous factors, Aetiology, Blood, Respiratory, Blood Preservation, Cytokines, Erythrocyte Transfusion, Erythrocytes, Humans, Inflammation, Respiration, Artificial, Thrombin, blood processing, cytokine and chemokine production, extracellular vesicles, mechanical ventilation, thrombin generation, Clinical Sciences, Medical Physiology, Cardiovascular System & Hematology, Clinical sciences
Abstract

BACKGROUND AND OBJECTIVES:Red-blood-cell (RBC) transfusion is associated with lung injury, which is further exacerbated by mechanical ventilation. Manufacturing methods of blood products differ globally and may play a role in the induction of pulmonary cell activation through alteration of the immunomodulatory property of the products. Here, the effect of different manufacturing methods on pulmonary cell activation was investigated in an in vitro model of mechanical ventilation. MATERIALS AND METHODS:Pulmonary type II cells were incubated with supernatant from fresh and old RBC products obtained via whole blood filtration (WBF), red cell filtration (RCF), apheresis-derived (AD) or whole blood-derived (WBD) methods. Lung cells were subjected to 25% stretch for 24 h. Controls were non-stretched or non-incubated cells. RESULTS:Fresh but not old AD products and WBF products induce lung cell production of pro-inflammatory cytokines and chemokines, which was not observed with WBD or RCF products. Effects were associated with an increased amount of platelet-derived vesicles and an increased thrombin-generating capacity. Mechanical stretching of lung cells induced more severe cell injury compared to un-stretched controls, including alterations in the cytoskeleton, which was further augmented by incubation with AD products. In all read-out parameters, RCF products seemed to induce less injury compared to the other products. CONCLUSIONS:Our findings show that manufacturing methods of RBC products impact pulmonary cell activation, which may be mediated by the generation of vesicles in the product. We suggest RBC manufacturing method may be an important factor in understanding the association between RBC transfusion and lung injury.

Published
2020

28. Ferric carboxymaltose infusion versus oral iron supplementation for preoperative iron deficiency anaemia in patients with colorectal cancer (FIT): a multicentre, open-label, randomised, controlled trial

Author

van Zweeden, Annette A, Hess, Daniel, Swank, Hilko A, Scholten, Lisette, van der Bilt, Jarmila D W, Jansen, Marilou A, van Duijvendijk, Peter, Bezuur, Donna, Carvello, Michele, Foppa, Caterina, de Vos tot Nederveen Cappel, Wouter H, Geitenbeek, Ritch T J, van Woensel, Lara, De Castro, Steve M M, Wientjes, Caroline, van Oostendorp, Stefan, Talboom, Kevin, Borstlap, Wernard A A, Roodbeen, Sapho X, Bruns, Emma R J, Buskens, Christianne J, Hompes, Roel, Tytgat, Kristien M A J, Tuynman, Jurriaan B, Consten, Esther C J, Heuff, Gijsbert, Kuiper, Teaco, van Geloven, Anna A W, Veldhuis, Gerrit J, van der Hoeven, Joost A B, Sietses, Colin, Spinelli, Antonino, van de Ven, Anthony W H, van der Zaag, Edwin S, Westerterp, Marinke, van Westreenen, Henderik L, Dijkgraaf, Marcel L, Juffermans, Nicole P, and Bemelman, Wilhelmus A

Published
2023
Full Text
View/download PDF

31. Plasma exchange in the intensive care unit: a narrative review

Author

Bauer, Philippe R., Ostermann, Marlies, Russell, Lene, Robba, Chiara, David, Sascha, Ferreyro, Bruno L., Cid, Joan, Castro, Pedro, Juffermans, Nicole P., Montini, Luca, Pirani, Tasneem, Van De Louw, Andry, Nielsen, Nathan, Wendon, Julia, Brignier, Anne C., Schetz, Miet, Kielstein, Jan T., Winters, Jeffrey L., and Azoulay, Elie

Published
2022
Full Text
View/download PDF

32. A consensus redefinition of transfusion‐related acute lung injury

Author

Vlaar, Alexander PJ, Toy, Pearl, Fung, Mark, Looney, Mark R, Juffermans, Nicole P, Bux, Juergen, Bolton‐Maggs, Paula, Peters, Anna L, Silliman, Christopher C, Kor, Daryl J, and Kleinman, Steve

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Rare Diseases, Acute Respiratory Distress Syndrome, Prevention, Lung, Detection, screening and diagnosis, 4.1 Discovery and preclinical testing of markers and technologies, Respiratory, Blood Transfusion, Consensus, Female, Humans, Male, Pulmonary Edema, Risk Factors, Transfusion-Related Acute Lung Injury, Cardiorespiratory Medicine and Haematology, Immunology, Cardiovascular System & Hematology, Cardiovascular medicine and haematology, Clinical sciences
Abstract

BackgroundTransfusion-related acute lung injury (TRALI) is a serious complication of blood transfusion and is among the leading causes of transfusion-related morbidity and mortality in most developed countries. In the past decade, the pathophysiology of this potentially life-threatening syndrome has been increasingly elucidated, large cohort studies have identified associated patient conditions and transfusion risk factors, and preventive strategies have been successfully implemented. These new insights provide a rationale for updating the 2004 consensus definition of TRALI.Study design and methodsAn international expert panel used the Delphi methodology to develop a redefinition of TRALI by modifying and updating the 2004 definition. Additionally, the panel reviewed issues related to TRALI nomenclature, patient conditions associated with acute respiratory distress syndrome (ARDS) and TRALI, TRALI pathophysiology, and standardization of reporting of TRALI cases.ResultsIn the redefinition, the term "possible TRALI" has been dropped. The terminology of TRALI Type I (without an ARDS risk factor) and TRALI Type II (with an ARDS risk factor or with mild existing ARDS) is proposed. Cases with an ARDS risk factor that meet ARDS diagnostic criteria and where respiratory deterioration over the 12 hours before transfusion implicates the risk factor as causative should be classified as ARDS. TRALI remains a clinical diagnosis and does not require detection of cognate white blood cell antibodies.ConclusionsClinicians should report all cases of posttransfusion pulmonary edema to the transfusion service so that further investigation can allow for classification of such cases as TRALI (Type I or Type II), ARDS, transfusion-associated circulatory overload (TACO), or TRALI or TACO cannot distinguish or an alternate diagnosis.

Published
2019

35. Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity

Author

Almizraq, Ruqayyah J, Norris, Philip J, Inglis, Heather, Menocha, Somaang, Wirtz, Mathijs R, Juffermans, Nicole, Pandey, Suchitra, Spinella, Philip C, Acker, Jason P, and Muszynski, Jennifer A

Subjects
Medical Biotechnology, Biomedical and Clinical Sciences, Clinical Research, Biomarkers, Blood Component Removal, Blood Preservation, Cell Separation, Coculture Techniques, Cytokines, Erythrocyte Transfusion, Erythrocytes, Extracellular Vesicles, Filtration, Flow Cytometry, Hemolysis, Humans, Immunomodulation, Leukocyte Count, Leukocytes, Monocytes, Cardiovascular medicine and haematology
Abstract

Transfusion of red cell concentrates (RCCs) is associated with increased risk of adverse outcomes that may be affected by different blood manufacturing methods and the presence of extracellular vesicles (EVs). We investigated the effect of different manufacturing methods on hemolysis, residual cells, cell-derived EVs, and immunomodulatory effects on monocyte activity. Thirty-two RCC units produced using whole blood filtration (WBF), red cell filtration (RCF), apheresis-derived (AD), and whole blood-derived (WBD) methods were examined (n = 8 per method). Residual platelet and white blood cells (WBCs) and the concentration, cell of origin, and characterization of EVs in RCC supernatants were assessed in fresh and stored supernatants. Immunomodulatory activity of RCC supernatants was assessed by quantifying monocyte cytokine production capacity in an in vitro transfusion model. RCF units yielded the lowest number of platelet and WBC-derived EVs, whereas the highest number of platelet EVs was in AD (day 5) and in WBD (day 42). The number of small EVs (

Published
2018

36. Mechanisms of red blood cell transfusion‐related immunomodulation

Author

Remy, Kenneth E, Hall, Mark W, Cholette, Jill, Juffermans, Nicole P, Nicol, Kathleen, Doctor, Allan, Blumberg, Neil, Spinella, Philip C, Norris, Philip J, Dahmer, Mary K, Muszynski, Jennifer A, and Network, for the Pediatric Critical Care Blood Research

Subjects
Biomedical and Clinical Sciences, Immunology, Clinical Research, Hematology, Aetiology, 2.1 Biological and endogenous factors, Blood, Animals, Erythrocyte Transfusion, Humans, Immune Tolerance, Immunologic Factors, Inflammation, Pediatric Critical Care Blood Research Network, Cardiorespiratory Medicine and Haematology, Clinical Sciences, Cardiovascular System & Hematology, Cardiovascular medicine and haematology, Clinical sciences
Abstract

Red blood cell (RBC) transfusion is common in critically ill, postsurgical, and posttrauma patients in whom both systemic inflammation and immune suppression are associated with adverse outcomes. RBC products contain a multitude of immunomodulatory mediators that interact with and alter immune cell function. These interactions can lead to both proinflammatory and immunosuppressive effects. Defining clinical outcomes related to immunomodulatory effects of RBCs in transfused patients remains a challenge, likely due to complex interactions between individual blood product characteristics and patient-specific risk factors. Unpacking these complexities requires an in-depth understanding of the mechanisms of immunomodulatory effects of RBC products. In this review, we outline and classify potential mediators of RBC transfusion-related immunomodulation and provide suggestions for future research directions.

Published
2018

37. The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19

Author

Atmowihardjo, Leila, Schippers, Job R., Bartelink, Imke H., Bet, Pierre M., van Rein, Nienke, Purdy, Keith, Cavalla, David, Comberiati, Valérie, McElroy, Andrew, Snape, Sue D., Bogaard, Harm Jan, Heunks, Leo, Juffermans, Nicole, Schultz, Marcus, Tuinman, Pieter R., Bos, Lieuwe D. J., and Aman, Jurjan

Published
2022
Full Text
View/download PDF

38. The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults

Author

Sieswerda, Elske, Bax, Hannelore I., Hoogerwerf, Jacobien J., de Boer, Mark G. J., Boermeester, Marja, Bonten, Marc J. M., Dekker, Douwe, van Wijk, Roy Gerth, Juffermans, Nicole P., Kuindersma, Marnix, van der Linden, Paul D., Melles, Damian C., Pickkers, Peter, Schouten, Jeroen A., Rebel, Jasper R., van Zanten, Arthur R. H., Prins, Jan M., and Wiersinga, W. Joost

Published
2022
Full Text
View/download PDF

42. Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine

Author

Vlaar, Alexander P. J., Dionne, Joanna C., de Bruin, Sanne, Wijnberge, Marije, Raasveld, S. Jorinde, van Baarle, Frank E. H. P., Antonelli, Massimo, Aubron, Cecile, Duranteau, Jacques, Juffermans, Nicole P., Meier, Jens, Murphy, Gavin J., Abbasciano, Riccardo, Müller, Marcella C. A., Lance, Marcus, Nielsen, Nathan D., Schöchl, Herbert, Hunt, Beverley J., Cecconi, Maurizio, and Oczkowski, Simon

Published
2021
Full Text
View/download PDF

45. Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial

Author

Aman, Jurjan, Duijvelaar, Erik, Botros, Liza, Kianzad, Azar, Schippers, Job R, Smeele, Patrick J, Azhang, Sara, Bartelink, Imke H, Bayoumy, Ahmed A, Bet, Pierre M, Boersma, Wim, Bonta, Peter I, Boomars, Karin A T, Bos, Lieuwe D J, van Bragt, Job J M H, Braunstahl, Gert-Jan, Celant, Lucas R, Eger, Katrien A B, Geelhoed, J J Miranda, van Glabbeek, Yurika L E, Grotjohan, Hans P, Hagens, Laura A, Happe, Chris M, Hazes, Boaz D, Heunks, Leo M A, van den Heuvel, Michel, Hoefsloot, Wouter, Hoek, Rianne J A, Hoekstra, Romke, Hofstee, Herman M A, Juffermans, Nicole P, Kemper, E Marleen, Kos, Renate, Kunst, Peter W A, Lammers, Ariana, van der Lee, Ivo, van der Lee, E Laurien, Maitland-van der Zee, Anke-Hilse, Mau Asam, Pearl F M, Mieras, Adinda, Muller, Mirte, Neefjes, Elisabeth C W, Nossent, Esther J, Oswald, Laurien M A, Overbeek, Maria J, Pamplona, Carolina C, Paternotte, Nienke, Pronk, Niels, de Raaf, Michiel A, van Raaij, Bas F M, Reijrink, Merlijn, Schultz, Marcus J, Serpa Neto, Ary, Slob, Elise M A, Smeenk, Frank W J M, Smit, Marry R, Smits, A Josien, Stalenhoef, Janneke E, Tuinman, Pieter R, Vanhove, Arthur L E M, Wessels, Jeroen N, van Wezenbeek, Jessie C C, Vonk Noordegraaf, Anton, de Man, Frances S, and Bogaard, Harm J

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results